As of 2026-04-02, 常山药业's data on the DeepSeek platform in the 国产5型磷酸二酯酶（PDE5）仿制药 category shows: The overall mention rate is 0.00%, below the industry average by 6.6 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 常山药业's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
常山药业's Mention Rate is 0.00%, lower than 0.6% of competitors
常山药业's First Mention is 0.00%, lower than 0.9% of competitors
常山药业's Preferred Rate is 0.00%, lower than 100.0% of competitors
常山药业's Positive Rate is 0.00%, lower than 8.9% of competitors
常山药业's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 金金戈 | 64.29% | 33.93% | 28.57% | 60.71% | 16.07% | View Details |
| 千千威 | 48.21% | 1.79% | 9.52% | 44.64% | 3.57% | View Details |
| 白白云山金戈 | 26.79% | 16.07% | 14.29% | 26.79% | 14.29% | View Details |
| 齐齐鲁制药 | 19.64% | 0% | 0% | 14.29% | 1.79% | View Details |
| 万万菲乐 | 17.86% | 0% | 0% | 14.29% | 0% | View Details |
| 白白云山 | 16.07% | 5.36% | 4.76% | 14.29% | 1.79% | View Details |
| 常常山药业 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
